These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10464888

  • 1. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
    Milanowski J, Qualtrough J, Perrin VL.
    Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [Abstract] [Full Text] [Related]

  • 3. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
    J Aerosol Med; 2002 Jan; 15(4):407-14. PubMed ID: 12581507
    [Abstract] [Full Text] [Related]

  • 4. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Jan; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

  • 5. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
    Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.
    Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL.
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG, Millar AB, Sykes AP.
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [Abstract] [Full Text] [Related]

  • 10. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
    Demedts M, Cohen R, Hawkinson R.
    Int J Clin Pract; 1999 Jun; 53(5):331-8. PubMed ID: 10695095
    [Abstract] [Full Text] [Related]

  • 11. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.
    Thompson PJ, Davies RJ, Young WF, Grossman AB, Donnell D.
    Respir Med; 1998 Jun; 92 Suppl A():33-9. PubMed ID: 9850361
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [Abstract] [Full Text] [Related]

  • 17. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [Abstract] [Full Text] [Related]

  • 18. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD, Walters EG.
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [Abstract] [Full Text] [Related]

  • 19. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL, Davidson PJ, Boudreau RJ.
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [Abstract] [Full Text] [Related]

  • 20. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.